GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

Cowealth Medical Holding Co 4745.TWO · TWD

Health Care · Taipei Exchange · 🇹🇼 Taiwan

Compare

10.25

-1.44%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in TWD, from our data supplier.

FY2025

Revenue

TWD 2.96bn

FY2016FY2025

Net income

−TWD 246.6m

FY2016FY2025

Free cash flow

TWD 836,000

FY2016FY2025

Shareholders' equity

TWD 2.87bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueTWD 2.96bnTWD 4.19bnTWD 4.81bnTWD 5.63bnTWD 5.14bnTWD 4.72bnTWD 4.67bnTWD 3.90bnTWD 3.04bnTWD 2.97bn
Gross profitTWD 392.2mTWD 791.5mTWD 996.5mTWD 1.10bnTWD 1.06bnTWD 1.02bnTWD 1.04bnTWD 984.0mTWD 787.0mTWD 849.5m
Research and developmentTWD 16.6mTWD 16.7mTWD 14.0mTWD 12.4m——————
Operating income−TWD 283.5mTWD 91.0mTWD 284.4mTWD 433.6mTWD 388.5mTWD 428.2mTWD 441.8mTWD 355.7mTWD 248.6mTWD 292.2m
Net income−TWD 246.6mTWD 629,000TWD 55.7mTWD 94.1mTWD 139.5mTWD 124.4mTWD 279.8mTWD 286.2mTWD 173.6mTWD 175.4m
Diluted earnings per share-3.010.010.731.221.801.613.423.492.122.19

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsTWD 7.04bnTWD 6.96bnTWD 6.64bnTWD 7.21bnTWD 5.40bnTWD 5.38bnTWD 5.41bnTWD 4.09bnTWD 3.63bnTWD 3.41bn
Cash and short-term investments——TWD 927.3mTWD 1.43bnTWD 842.7mTWD 1.21bn———TWD 393.3m
Total liabilitiesTWD 1.99bnTWD 1.76bnTWD 1.61bnTWD 2.00bnTWD 1.88bnTWD 1.95bnTWD 2.07bnTWD 2.20bnTWD 1.97bnTWD 1.83bn
DebtTWD 8.5m—TWD 647.2mTWD 956.2mTWD 913.3mTWD 984.7mTWD 137.8mTWD 89.7mTWD 194.4mTWD 1.01bn
Shareholders' equityTWD 2.87bnTWD 2.80bnTWD 2.72bnTWD 2.84bnTWD 2.57bnTWD 2.55bnTWD 2.44bnTWD 1.83bnTWD 1.66bnTWD 1.58bn
Shares outstanding82m82m76m77m77m77m82m82m82m80m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsTWD 15.5mTWD 469.4mTWD 45.0m−TWD 267.6m−TWD 118.4mTWD 804.8m−TWD 136.8mTWD 133.6mTWD 135.3m—
Capital spending−TWD 14.7m−TWD 62.3m−TWD 236.5m−TWD 26.4m−TWD 36.7m−TWD 28.1m−TWD 89.2m−TWD 59.9m−TWD 40.7m—
Free cash flowTWD 836,000TWD 407.1m−TWD 191.5m−TWD 294.0m−TWD 155.0mTWD 776.7m−TWD 226.0mTWD 73.8mTWD 94.6m—
Dividends paid—−TWD 31.0m−TWD 123.9m−TWD 116.2m−TWD 92.9m−TWD 88.5m−TWD 18.4m−TWD 11.5m−TWD 115.4m—

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueTWD 853.8mTWD 702.1mTWD 571.9mTWD 771.5mTWD 818.5mTWD 794.3mTWD 1.02bnTWD 1.04bn
Gross profitTWD 143.5mTWD 116.0mTWD 31.1mTWD 116.0mTWD 119.2mTWD 125.9mTWD 173.5mTWD 192.0m
Operating incomeTWD 13.0m−TWD 53.5m−TWD 124.0m−TWD 48.5mTWD 1.1m−TWD 52.5m—TWD 30.0m
Net income−TWD 24.6m−TWD 31.2m−TWD 160.7m−TWD 31.9m−TWD 23.5m−TWD 30.5mTWD 6.2m−TWD 5.9m
Diluted earnings per share-0.30-0.38-1.96-0.39-0.29-0.370.08-0.07
Cash from operationsTWD 350.0m−TWD 342.0m−TWD 481.0m−TWD 85.0mTWD 508.0mTWD 74.0mTWD 637.0mTWD 52.0m
Capital spending−TWD 4.0m—−TWD 5.0m−TWD 2.0m−TWD 5.0m−TWD 1.0m−TWD 7.0m−TWD 1.0m
Free cash flowTWD 346.0m—−TWD 486.0m−TWD 87.0mTWD 503.0mTWD 73.0mTWD 630.0mTWD 51.0m
Total assetsTWD 7.19bnTWD 7.18bnTWD 7.04bnTWD 6.65bnTWD 6.64bnTWD 7.31bnTWD 6.96bnTWD 6.82bn
DebtTWD 40.9mTWD 23.3mTWD 8.5mTWD 10.2mTWD 11.9mTWD 13.5m—TWD 2.4m
Shareholders' equityTWD 2.70bnTWD 2.91bnTWD 2.87bnTWD 2.57bnTWD 2.46bnTWD 2.82bnTWD 2.80bnTWD 2.80bn

Financial ratios

Data as of 1 Nov 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin13.3%18.9%20.7%19.6%20.6%21.7%
Operating margin-8.9%2.8%5.9%7.7%7.6%9.1%
Net margin-8.3%0.0%1.2%1.7%2.7%2.6%
Return on equity-8.6%0.0%2.0%3.3%5.4%4.9%
Return on assets-3.5%0.0%0.8%1.3%2.6%2.3%
Free cash flow yield—55.0%31.3%-26.4%-8.9%91.1%
Revenue growth-29.5%-12.9%-14.5%9.5%8.8%1.2%
Earnings growth-39298.3%-98.9%-40.8%-32.5%12.1%-55.5%
Current ratio2.79x3.39x3.61x3.34x2.75x2.60x
Debt to equity0.00x0.00x0.23x0.33x0.34x0.37x
Equity ratio40.8%40.2%41.0%39.3%47.5%47.3%
Interest coverage-11.55x4.07x8.19x17.37x15.93x11.84x
R&D as a share of sales0.6%0.4%0.3%0.2%——
Buybacks as a share of market value—-7.5%1.6%0.0%0.0%—

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-19.3%-8.9%-1.0%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin16.6%18.7%19.5%22.0%
Operating margin-2.7%3.0%4.9%6.5%
Net margin-3.4%-0.5%0.6%3.2%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings-8.4—35.320.414.819.811.69.113.316.4
Price to sales0.70.40.40.30.40.50.70.70.81.0

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years. Last went ex-dividend on 27 Jun 2024.

FY2024FY2023FY2022
Paid in the year0.401.601.50
  • 1050-for-1000 split · 16 Jul 2020
  • 1200-for-1000 split · 5 Aug 2019
  • 1100-for-1000 split · 5 Jul 2018
  • 1019.972-for-1000 split · 16 Jul 2015

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.